Infectious complications after simultaneous pancreas-kidney transplantation: A role for the lectin pathway of complement activation

Transplantation

Volumn 85, Issue 1, 2008, Pages 75-80

  Verschuren, Jeffrey J W ^a   Roos, Anja ^a   Schaapherder, Alexander F M ^a   Mallat, Marko J K ^a   Daha, Mohamed R ^a   De Fijter, Johan W ^a   Berger, Stefan P ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Complement; Infections; Mannose binding lectin; Simultaneous pancreas kidney transplantation

Indexed keywords

ACICLOVIR; AMPHOTERICIN B; AZATHIOPRINE; COTRIMOXAZOLE; CYCLOSPORIN; DACLIZUMAB; GANCICLOVIR; MANNOSE BINDING LECTIN; MICONAZOLE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; PREDNISONE; THYMOCYTE ANTIBODY; VALACICLOVIR;

ADULT; ARTICLE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; CYSTITIS; CYTOMEGALOVIRUS INFECTION; DRUG MEGADOSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; INFECTION COMPLICATION; KIDNEY PANCREAS TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCORING SYSTEM; SEPSIS; STOMATITIS; URINARY TRACT INFECTION; VAGINITIS; WOUND INFECTION;

ADULT; BIOLOGICAL MARKERS; COMPLEMENT ACTIVATION; DISEASE SUSCEPTIBILITY; FEMALE; GRAFT SURVIVAL; HUMANS; IMMUNITY, NATURAL; KIDNEY TRANSPLANTATION; MALE; MANNOSE-BINDING LECTIN; MIDDLE AGED; MULTIVARIATE ANALYSIS; PANCREAS TRANSPLANTATION; RETROSPECTIVE STUDIES; RISK FACTORS; SEPSIS; URINARY TRACT INFECTIONS;

EID: 38149126487     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000297249.10654.f5     Document Type: Article

References (23)

1. Demartines N, Schiesser M, Clavien PA. An evidence-based analysis of simultaneous pancreas-kidney and pancreas transplantation alone. Am J Transplant 2005; 5: 2688.
2. Smets YF, van der Pijl JW, van Dissel JT, Ringers J, de Fijter JW, Lemkes HH. Infectious disease complications of simultaneous pancreas kidney transplantation. Nephrol Dial Transplant 1997; 12: 764.
3. Pratt JR, Basheer SA, Sacks SH. Local synthesis of complement component C3 regulates acute renal transplant rejection. Nat Med 2002; 8: 582.
4. Brown KM, Kondeatis E, Vaughan RW, et al. Influence of donor C3 allotype on late renal-transplantation outcome. N Engl J Med 2006; 354: 2014.
5. Berger SP, Roos A, Mallat MJ, et al. Low pretransplantation mannose-binding lectin levels predict superior patient and graft survival after simultaneous pancreas-kidney transplantation. J Am Soc Nephrol 2007; 18: 2416.
6. Walsh MC, Bourcier T, Takahashi K, et al. Mannose-binding lectin is a regulator of inflammation that accompanies myocardial ischemia and reperfusion injury. J Immunol 2005; 175: 541.
7. Moller-Kristensen M, Wang W, Ruseva M, et al. Mannan-binding lectin recognizes structures on ischaemic reperfused mouse kidneys and is implicated in tissue injury. Scand J Immunol 2005; 61: 426.
8. Garred P, Pressler T, Madsen HO, et al. Association of mannose-binding lectin gene heterogeneity with severity of lung disease and survival in cystic fibrosis. J Clin Invest 1999; 104: 431.
9. Koch A, Melbye M, Sorensen P, et al. Acute respiratory tract infections and mannose-binding lectin insufficiency during early childhood. JAMA 2001; 285: 1316.
10. Peterslund NA, Koch C, Jensenius JC, Thiel S. Association between deficiency of mannose-binding lectin and severe infections after chemotherapy. Lancet 2001; 358: 637.
11. Mullighan CG, Heatley S, Doherty K, et al. Mannose-binding lectin gene polymorphisms are associated with major infection following allogeneic hemopoietic stem cell transplantation. Blood 2002; 99: 3524.
12. Bouwman LH, Roos A, Terpstra OT, et al. Mannose binding lectin gene polymorphisms confer a major risk for severe infections after liver transplantation. Gastroenterology 2005; 129: 408.
13. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988; 16: 128.
14. Roos A, Bouwman LH, Gijlswijk-Janssen DJ, Faber-Krol MC, Stahl GL, Daha MR. Human IgA activates the complement system via the mannan-binding lectin pathway. J Immunol 2001; 167: 2861.
15. Berger SP, Roos A, Mallat MJ, Fujita T, de Fijter JW, Daha MR. Association between mannose-binding lectin levels and graft survival in kidney transplantation. Am J Transplant 2005; 5: 1361.
16. Roos A, Garred P, Wildenberg ME, et al. Antibody-mediated activation of the classical pathway of complement may compensate for mannose-binding lectin deficiency. Eur J Immunol 2004; 34: 2589.
17. Neth O, Jack DL, Dodds AW, Holzel H, Klein NJ, Turner MW. Mannose-binding lectin binds to a range of clinically relevant microorganisms and promotes complement deposition. Infect Immun 2000; 68: 688.
18. Kuhlman M, Joiner K, Ezekowitz RA. The human mannose-binding protein functions as an opsonin. J Exp Med 1989; 169: 1733.
19. Dahl M, Tybjaerg-Hansen A, Schnohr P, Nordestgaard BG. A population-based study of morbidity and mortality in mannose-binding lectin deficiency. J Exp Med 2004; 199: 1391.
20. Steffensen R, Thiel S, Varming K, Jersild C, Jensenius JC. Detection of structural gene mutations and promoter polymorphisms in the mannan-binding lectin (MBL) gene by polymerase chain reaction with sequence-specific primers. J Immunol Methods 2000; 241: 33.
21. Van Till JW, Boermeester MA, Modderman PW, et al. Variable mannose-binding lectin expression during postoperative acutephase response. Surg Infect (Larchmt) 2006; 7: 443.
22. Manuel O, Pascual M, Trendelenburg M, Meylan PR. Association between mannose-binding lectin deficiency and cytomegalovirus infection after kidney transplantation. Transplantation 2007; 83: 359.
23. Cervera C, Lozano F, Saval N, et al. The influence of innate immunity gene receptors polymorphisms in renal transplant infections. Transplantation 2007; 83: 1493.